Skip to main content
SpringerLink
Log in

Remifentanil Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Downregulating the NF-κB Signaling Pathway

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Remifentanil significantly represses cell immune responses and influences neutrophil migration through endothelial cell monolayers. The present study determines the beneficial effects of remifentanil and the mechanisms by which it attenuates lipopolysaccharide (LPS)-induced acute lung injury (ALI). Rats were intratracheally instilled with 2 mg/kg LPS to induce ALI. Results showed that remifentanil could resolve lung injury, as evidenced by remarkable decreases in lung edema (wet-to-dry weight ratio), neutrophil infiltration (myeloperoxidase activity), and pulmonary permeability [total number of cells and protein concentrations in bronchoalveolar lavage fluid (BALF)]. Remifentanil also attenuated the concentrations of proinflammatory cytokines tumor necrosis factor alpha, interleukin-1β, and interleukin-6 in BALF, as well as effectively repressed the activation of nuclear factor-kappaB (NF-κB), which has been associated with the inhibition of IκBα degradation.These results suggest that remifentanil may be a suitable treatment for LPS-induced ALI. Remifentanil exerts beneficial effects on the inhibition of proinflammatory cytokine production by downregulating the NF-κB pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. New England Journal of Medicine 342: 1334–1349.

    Article  PubMed  CAS  Google Scholar 

  2. Brigham, K.L., and B. Meyrick. 1986. Endotoxin and lung injury. American Review of Respiratory Diseases 133: 913–927.

    CAS  Google Scholar 

  3. Matute-Bello, G., C.W. Frevert, and T.R. Martin. 2008. Animal models of acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 295: L379–L399.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Li, G., J. Li, Q. Zhou, X. Song, H. Liang, and L. Huang. 2010. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats. Tohoku Journal of Experimental Medicine 222: 7–13.

    Article  PubMed  CAS  Google Scholar 

  5. Xu, C.Q., B.J. Liu, J.F. Wu, Y.C. Xu, X.H. Duan, Y.X. Cao, and J.C. Dong. 2010. Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-kappaB signaling pathway. European Journal of Pharmacology 642: 146–153.

    Article  PubMed  CAS  Google Scholar 

  6. Kwak, J.H., S.W. Won, T.J. Kim, E. Roh, H.Y. Kang, H.W. Lee, J.K. Jung, B.Y. Hwang, Y. Kim, J. Cho, and H. Lee. 2008. Synthesis of chroman-2-carboxylic acid N-(substituted)phenylamides and their inhibitory effect on nuclear factor-kappaB (NF-kappaB) activation. Archives of Pharmacal Research 31: 133–141.

    Article  PubMed  CAS  Google Scholar 

  7. Mason, P. 2002. Remifentanil. Intensive Critical Care Nurse 18: 355–357.

    Article  Google Scholar 

  8. Zongze, Z., Z. Jia, C. Chang, C. Kai, and W. Yanlin. 2010. Protective effects of remifentanil on septic mice. Molecular Biology Reports 37: 2803–2808.

    Article  PubMed  Google Scholar 

  9. Sacerdote, P., L. Gaspani, G. Rossoni, A.E. Panerai, and M. Bianchi. 2001. Effect of the opioid remifentanil on cellular immune response in the rat. International Immunopharmacology 1: 713–719.

    Article  PubMed  CAS  Google Scholar 

  10. Hofbauer, R., M. Frass, B. Gmeiner, N. Sandor, R. Schumann, O. Wagner, and A.D. Kaye. 2000. Effects of remifentanil on neutrophil adhesion, transmigration, and intercellular adhesion molecule expression. Acta Anaesthesiologica Scandinavica 44: 1232–1237.

    Article  PubMed  CAS  Google Scholar 

  11. Hartree, E.F. 1972. Determination of protein: A modification of the Lowry method that gives a linear photometric response. Analytical Biochemistry 48: 422–427.

    Article  PubMed  CAS  Google Scholar 

  12. Song, X.M., J.G. Li, Y.L. Wang, Z.F. Hu, Q. Zhou, Z.H. Du, and B.H. Jia. 2008. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 30: 468–472.

    Article  PubMed  CAS  Google Scholar 

  13. Andrews, N.C., and D.V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 19: 2499.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Kwak, S.H., J.I. Choi, and J.T. Park. 2004. Effects of propofol on endotoxin-induced acute lung injury in rabbit. Journal of Korean Medical Science 19: 55–61.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Lin, Y., X. Zhu, W.Z. Yao, Y.L. Yang, L. T. A., and L. Chen. 2011. Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats. Chinese Medical Journal (English) 124: 1069–1074.

    CAS  Google Scholar 

  16. Goodman, R.B., J. Pugin, J.S. Lee, and M.A. Matthay. 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine & Growth Factor Reviews 14: 523–535.

    Article  CAS  Google Scholar 

  17. Minamino, T., and I. Komuro. 2006. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. Journal of Clinical Investigation 116: 2316–2319.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: Four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Paladino, J.D., J.R. Hotchkiss, and H. Rabb. 2009. Acute kidney injury and lung dysfunction: A paradigm for remote organ effects of kidney disease? Microvascular Research 77: 8–12.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  20. Hopkins, S.J. 2003. The pathophysiological role of cytokines. Legal Medicine (Tokyo) 1: S45–S57. 5 Suppl.

    Article  Google Scholar 

  21. Ke, J.J., J. Zhan, X.B. Feng, Y. Wu, Y. Rao, and Y.L. Wang. 2008. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesthesia and Intensive Care 36: 74–78.

    PubMed  CAS  Google Scholar 

  22. Fan, J., R.D. Ye, and A.B. Malik. 2001. Transcriptional mechanisms of acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 281: L1037–L1050.

    PubMed  CAS  Google Scholar 

  23. Schwartz, M.D., E.E. Moore, F.A. Moore, R. Shenkar, P. Moine, J.B. Haenel, and E. Abraham. 1996. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Critical Care Medicine 24: 1285–1292.

    Article  PubMed  CAS  Google Scholar 

  24. Blackwell, T.S., T.R. Blackwell, E.P. Holden, B.W. Christman, and J.W. Christman. 1996. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. Journal of Immunology 157: 1630–1637.

    CAS  Google Scholar 

  25. Liu, S.F., X. Ye, and A.B. Malik. 1997. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. Journal of Immunology 159: 3976–3983.

    CAS  Google Scholar 

  26. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 279: L1137–L1145.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was financially supported by the National Natural Science Foundation of China (no. 30972852).

Author information

Authors and Affiliations

  1. Department of Anesthesia, Critical Care Medicine & Emergency Medicine Center, Zhongnan Hospital, Wuhan University, Wuhan, 430071, Hubei Province, People’s Republic of China

    Ying Zhang, Zhaohui Du, Qing Zhou, Yanlin Wang & Jianguo Li

Authors
  1. Ying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaohui Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qing Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanlin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jianguo Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jianguo Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Du, Z., Zhou, Q. et al. Remifentanil Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Downregulating the NF-κB Signaling Pathway. Inflammation 37, 1654–1660 (2014). https://doi.org/10.1007/s10753-014-9893-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-9893-2

KEY WORDS

Search

Navigation